---
layout: minimal-medicine
title: Interferon alfacon-1
---

# Interferon alfacon-1
### Generic Name
Interferon alfacon-1

### Usage
Interferon alfacon-1 is a synthetic version of a type 1 interferon primarily used to treat chronic Hepatitis C (HCV) in adults (18 years and older) with compensated liver disease.  It's crucial to understand that interferon alfacon-1 monotherapy for HCV is generally not recommended unless a patient cannot tolerate ribavirin, another medication often used in combination therapy.  The drug's mechanism involves modulating the immune response and directly inhibiting viral replication.

### Dosage

**Adults:** The dosage of interferon alfacon-1 varies greatly depending on whether it's used as monotherapy or in combination with ribavirin.

* **Monotherapy for Chronic Hepatitis C:**  The initial recommended dose is 9 mcg administered subcutaneously three times a week for 24 weeks.  For patients who have previously tolerated interferon therapy but didn't respond or relapsed, a higher dose of 15 mcg three times a week for up to 48 weeks may be considered.  It's vital to note that patients who couldn't tolerate standard interferon therapy shouldn't receive the higher 15 mcg dose.

* **Combination Therapy with Ribavirin for Chronic Hepatitis C:** The recommended dose is 15 mcg of interferon alfacon-1 given subcutaneously daily, combined with ribavirin (dosage based on weight: 1000-1200 mg daily, divided into two doses). This combination therapy is usually given for up to 48 weeks.

**Children:** The safety and efficacy of interferon alfacon-1 have not been established in children under 18 years old.  It's not recommended for pediatric use.

**Dosage Adjustments:** Dosage adjustments might be necessary based on the patient's response and the occurrence of adverse events. In cases of serious side effects, the dose might be reduced or treatment temporarily stopped.  Specific adjustments for hepatic or renal impairment are also critical.  Patients with decompensated liver disease (Child-Pugh class B or C) or creatinine clearance (CrCl) below 50 mL/min (when used with ribavirin) should not receive this medication.

### Side Effects

Common side effects (occurring in more than 10% of patients) often include headache, fatigue, fever, chills, muscle aches (myalgia), body pain, joint pain (arthralgia), and back pain.  Less common but still important side effects include abnormal liver function test results, amnesia, constipation, changes in menstruation, decreased libido, bronchitis, nosebleeds, hypertension, palpitations, and vaginitis.  Rare but serious side effects such as vision loss or retinopathy can also occur.  Any new or worsening symptoms should be reported to a healthcare professional immediately.


### How it Works

Interferon alfacon-1 belongs to the alpha-interferon family. These proteins naturally occur in the body and have antiviral, antiproliferative, and immune-regulating properties.  The drug binds to receptors on cells, triggering several effects within the body. These include boosting the immune system's ability to fight the virus, interfering with the virus's ability to replicate, and slowing or stopping the growth of infected cells.  In the context of Hepatitis C, this multi-pronged action helps to control the viral load and reduce liver damage.

### Precautions

* **Contraindications:** Interferon alfacon-1 is contraindicated in patients with hypersensitivity to interferons or any component of the medication, decompensated liver disease (Child-Pugh classes B and C), autoimmune hepatitis, and pregnant women, or men whose partners are pregnant. Individuals with hemoglobinopathies or CrCl <50 mL/min (when combined with ribavirin) should also avoid it.

* **Interactions:** Interferon alfacon-1 can interact with several other drugs, potentially increasing the risk of side effects or altering the effectiveness of other medications. These interactions are complex and need careful consideration by healthcare professionals.  Examples include interactions with aldesleukin, BCG, clozapine, deferiprone, dipyrone, methadone, and theophylline derivatives.  Interaction with ribavirin is particularly important as it carries increased risks of hemolytic anemia and teratogenicity.


* **Warnings:**  There's a boxed warning highlighting the potential for life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Close monitoring is crucial, and treatment should be stopped if severe symptoms persist or worsen.  When used with ribavirin, the risk of birth defects is significant, requiring strict pregnancy prevention measures.  The medication also carries the risk of several other serious side effects including cardiovascular events, pulmonary disorders, hepatic failure, renal insufficiency, cerebrovascular events, bone marrow toxicity, colitis, and pancreatitis.


### FAQs

* **Q: How is interferon alfacon-1 administered?**
    *A: It's administered via subcutaneous injection.

* **Q: How long does treatment typically last?**
    *A: Treatment duration varies, but it usually ranges from 24 to 48 weeks, depending on the dosage and combination therapy.

* **Q: What should I do if I experience side effects?**
    *A: Contact your healthcare provider immediately.  Some side effects require immediate medical attention.

* **Q: Can I drink alcohol while on this medication?**
    *A:  It's advisable to discuss alcohol consumption with your doctor as it could potentially interact with the medication or worsen liver conditions.

* **Q: How should I store interferon alfacon-1?**
    *A: Follow the storage instructions provided with your prescription.

* **Q: Is this medication safe for pregnant or breastfeeding women?**
    *A: No, interferon alfacon-1 is contraindicated during pregnancy and breastfeeding.

**Disclaimer:**  This information is for educational purposes only and does not constitute medical advice. Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  Individual responses to medication vary, and this overview does not cover all possible side effects or interactions.
